Cannabis

AuthorEuropean Monitoring Centre for Drugs and Drug Addiction (EU body or agency), Europol (EU body or agency)
Pages82-101
82
Key points
Cannabis in Europe
Cannabis is the biggest drug market in the EU and
amajor source of income for the criminal economy.
With around 25 million people reporting having used
the drug in the past year, the retail market for cannabis
is conservatively estimated to be worth at least
EUR11.6billion.
Europe is amajor cannabis producer; it is estimated that
at least 20000 cannabis cultivation sites are dismantled in
the EU each year, although the number of sites producing
cannabis at any given time is likely to be much higher.
Diversity in OCG involvement and levels of intergroup
violence appear to be increasing. OCGs of Moroccan origin
still play amajor role in cannabis resin tracking, and
groups of Dutch origin especially, but also of Vietnamese
origin, are important for large-scale production. However,
more generally, involvement in the cannabis market can
be an important cash generator for both established and
emerging OCGs, leading to increased intergroup violence.
e cannabis market is becoming more diverse and
complex. Illicitly produced herbal cannabis and cannabis
resin continue to be the most commonly used forms of
cannabis and tend to be much more potent than in the
past. e market now also includes high-potency cannabis
oils, synthetic cannabinoids, cannabis and cannabinoid
products and preparations intended for medical use, and
an increasing number of cannabidiol (CBD) or low-THC
products being sold in arange of forms. e regulatory
status of these varies considerably, posing new challenges
for law enforcement, regulation and monitoring.
Consumption estimates generally appear stable, with
around one in seven young adults (aged 15-34) in the EU
reporting having used cannabis in the last year, although
there are recent signs of increases in younger age cohorts
in some countries.
Developments in production and
tracking
Production near to, or by, consumers creates additional
challenges for law enforcement. Alarge proportion of the
herbal cannabis consumed in the EU is grown there, closer
to its place of consumption, rather than being imported
from outside the EU, reducing the need to trac the drug
across external borders and lowering the risk of interdiction.
is and how to address small-scale production, which
is tolerated in some Member States, creates amore
challenging landscape for law enforcement actions.
Morocco’s Rif Mountains are the region of origin of
most of the cannabis resin available in Europe. Increased
cooperation with European cannabis producers appears
to explain the spread of high-yield, high-potency varieties
of cannabis in this region and therefore the increase in the
potency of cannabis resin observed in Europe over the last
10 years.
Cannabis production causes arange of environmental
harms. In Morocco it has been associated with soil
erosion, deforestation and water security issues, probably
exacerbated by the introduction of new plant strains. In the
EU, production is also linked to environmental, and health
and safety risks.
Diusion is evident in cannabis resin tracking routes.
While Spain remains the main entry point into the EU, the
CHAPTER 3
Cannabis
EU DRUG MARKETS REPORT
83
tracking of resin produced in Morocco and Lebanon now
aects the Mediterranean Sea region as awhole, following
the emergence of Libya as amajor storage and transit hub
for the drug.
e Netherlands and Spain are commonly identied as
the source of origin of seizures made by EU countries. In
addition, despite eorts to counter production, the Western
Balkans, and Albania in particular, appears to remain an
important source of origin for herbal cannabis seizures.
e frequency of small-volume online cannabis sales is
increasing. Although the scale is currently small compared
with traditional retail markets, it has considerable potential
to grow.
Implications for action to address
current threats and increase
preparedness
To identify and respond to new threats related to the
cannabis market there is aneed to take the following
actions.
Give high priority to sharing information and best
practice on law enforcement strategies to detect
signicant cannabis production sites in the EU,
including models for cooperation with relevant utility
services, and strengthen the standardised reporting of
interdiction activities in this area.
Improve the monitoring and assess the impact of
trends in cannabis products available on the EU
markets. is requires better forensic evidence on the
content and sources of cannabis seizures as well as
the identication of any new higher-potency forms of
cannabis appearing on the market.
Invest greater eorts in monitoring, analysis and
information sharing to understand the dynamics
of cannabis tracking and production in countries
bordering the EU. Crop-monitoring programmes in
close cooperation with important countries such as
Albania and Morocco would contribute to this.
Strengthen EU interagency cooperation and develop
targeted enforcement actions to identify and respond
to any threats resulting from Libya’s emerging role as
asignicant storage and transit country.
Follow closely and assess the implications for
the cannabis market, and the potential risks, of
commercial, medical and regulatory developments
occurring internationally and within EU Member States.
Strengthen coordination of activities at EU level to
ensure that the roles and responsibilities of various
partners, including law enforcement and regulatory
bodies, are well articulated.
CHAPTER 3
I
Cannabis

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT